Role of phototherapy in the era of biologics
The result is lighter sleep, more frequent awakenings, and a feeling of not being rested even after spending adequate time in bed
Biomedical Optics Express
Based on the current stage of clinical development and estimated trial completion dates registered on ClinicalTrials.gov, a realistic earliest possible timeline might be considered as follows: 20252026: Completion of key phase 3 TRIUMPH trial data 20262027: Potential regulatory submission to the MHRA (and FDA/EMA in parallel) 20272028: Possible MHRA marketing authorisation, subject to satisfactory review 2028 onwards: NICE technology appraisal and potential NHS commissioning decision These timelines are speculative and depend on multiple variables, including trial outcomes, the completeness of the regulatory submission, MHRA review timelines, and NICE deliberations
The right response depends on the product and the patient
The results depend on factors such as adherence to the medication, lifestyle changes, and overall health